Recent developments in pleurodesis for malignant pleural disease.
Julien GuindeSamer GeorgesValerian BourinetSophie LaroumagneHerve DutauPhilippe AstoulPublished in: The clinical respiratory journal (2019)
Treatment approaches of recurrent MPE should take into account multiple factors in particular patient's life expectancy and preference. If talc is the best sclerosing agent alone or in combination with indwelling pleural catheter which is a promising strategy, the pathophysiology of MPE has to be revisited in order to propose a personalized management targeting intrapleural key molecules involved in the genesis of malignant process.